Akasa

AKASA is a specialized AI platform designed to automate and optimize the complex healthcare revenue cycle. Its core value proposition lies in applying generative AI and machine learning to streamline administrative and financial workflows, thereby reducing costs, minimizing errors, and accelerating revenue collection for healthcare providers. By focusing on the unique data and regulatory challenges of healthcare, it transforms traditionally manual, error-prone processes into efficient, intelligent operations.

Key features: The platform automates a wide range of revenue cycle tasks with concrete applications. For prior authorization, it can gather necessary clinical documentation and submit requests. For clinical documentation improvement (CDI), it reviews charts in real-time to suggest more accurate and specific codes. In medical coding, it automatically suggests and assigns appropriate ICD-10, CPT, and HCPCS codes from clinical notes. For claims management, it automates claims scrubbing, submission, and denial management, identifying errors before submission and generating appeal letters for denied claims.

What sets AKASA apart is its unified, AI-native approach built specifically for healthcare's financial operations, unlike generic automation tools. It employs large language models (LLMs) trained on vast, proprietary datasets of clinical and financial information, enabling deep understanding of medical terminology and payer rules. The system is designed to learn and adapt from each interaction within a healthcare organization's unique environment. It integrates seamlessly with major Electronic Health Record (EHR) and hospital information systems, acting as a co-pilot that works alongside existing staff without requiring massive IT overhauls.

Ideal for hospitals, health systems, physician groups, and medical billing companies seeking to improve financial performance and operational efficiency. Specific use cases include organizations struggling with coding backlogs, high denial rates, lengthy prior authorization times, and the need for more accurate clinical documentation to support risk-adjusted payment models. It is particularly valuable in the US healthcare market where reimbursement complexity is high.

Pricing follows a freemium model with a free tier for basic exploration, while full enterprise automation capabilities require a custom quote typically based on the scale and modules deployed, with costs justified by significant ROI through recovered revenue and reduced labor expenses.